Alan B Scott, MD
|
|
Director & Senior Scientist at The Strabismus Research Foundation (SRF), and Senior Scientist at Eidactics (2013-2021).
Senior Scientist at The Smith-Kettlewell Eye Research Institute (SKERI; 1959-2016).
|
Honors
| Phi Beta Kappa | | Linksz Medal of the International Strabismological Association | | Senior Honor Award of the American Academy of Ophthalmology | | Costenbader Lecturer, American Association for Pediatric Ophthalmology and Strabismus | | Harvey Thorpe Lecturer, Pittsburgh Ophthalmology Society | | Hall of Fame Award, Benign Essential Blepharospasm Research Foundation | | Proctor Lecturer, Association for Research in Vision and Opthalmology | | Marshall M. Parks Lecturer, American Academy of Ophthalmology | | Howe Medal, American Ophthalmological Society |
Training & Experience
| Hospital Staff Appointment, California Pacific Medical Center, San Francisco, CA (1961-2016). | | Executive Director, Smith-Kettlewell Eye Research Institute, San Francisco, CA (1992-2003) | | Co-Director, Smith-Kettlewell Eye Research Institute, San Francisco, CA (1980-1992). | | Senior Scientist (Clinical), Smith-Kettlewell Eye Research Institute, San Francisco, CA (1960-2016). | | M.D., University of California Medical School, San Francisco, CA (1956). | | A.B. in Medical Science, University of California, Berkeley, CA (1953). |
Grants & Awards
| Principal Investigator, Pacific Vision Foundation (1 Oct 2013 - 30 Sep 2014): "Accurate Injection of Eye Muscles in Children" | | Principal Investigator, NIH/NEI Project 1 R01 EY018633-01 (1 Sep 2009 - 31 Aug 2014): "Extraocular Muscle (EOM Responses to Bupivacaine Injection" | | Principal Investigator, Pacific Vision Foundation (1 Oct 2008 - 30 Sep 2009): "Bupivacaine in Underperforming Muscles" | | Principal Investigator, The Smith-Kettlewell Eye Research Institute (1 Jan 2008 - 31 Dec 2008): "Studies of Extraocular Muscle Function" |
Professional Citizenship
| Visual Sciences Study Section B, National Institutes of Health, Bethesda, MD (1983-1986).
Visual Research Program Committee, National Institutes of Health, Bethesda, MD (1978-1982).
| | Administrative Council, International Strabismological Association, (1978-1986). |
Selected Publications
| Scott AB, Miller JM, Danh KK (2013). Bupivacaine shortens eye muscles and corrects strabismus. Presentation at 149th Annual Meeting, American Ophthalmological Society. San Diego, CA, USA. (Injection Video). | | Scott AB, Miller JM, Danh KK (2013). Bupivacaine injection of eye muscles to treat strabismus. Pediatric Ophthalmology and Strabismus, Hoyt CS, Taylor D, ch 87, pgs 896-900, pub Elsevier. | | Miller JM, Scott AB, Danh KK, Strasser D, Sane M (2012). Bupivacaine injection remodels extraocular muscles & corrects comitant strabismus. Ophthalmology, vol 120, isu 12, pgs 2733-2740. (Authors' Cut PDF; Publisher's site). | | Scott AB, Miller JM, Shieh BS (2009). Treating strabismus by injecting the agonist muscle with bupivacaine and the antagonist with botulinum toxin. Transactions of the American Ophthamological Society, vol 107, pgs 104-109. | | Scott AB, Miller JM, Shieh BS (2009). Bupivacaine injection of the lateral rectus muscle to treat esotropia. Journal of AAPOS, vol 13, pgs 119-122. | |
Scott AB, Alexander DE, Miller JM (2007).
Bupivacaine Injection of Eye Muscles to Treat Strabismus
.
Br J Ophthalmol; 91(2): 146-8.
|
| Morad Y, Kowal L, Scott AB. Lateral Rectus muscle disinsertion and reattachment to the lateral orbital wall. Br J Ophthalmol. 2005; 89(8): 983-5. | | Souza-Dias C, Scott AB, Wang AH. Progressive restrictive strabismus acquired in infancy. Br J Ophthalmol. 2005; 89(8): 986-7. | | Scott AB (2004). Development of botulinum toxin therapy. In: Dermatol Clin. Apr; 22(2): 131-3. | | McNeer KW, Magoon EH, Scott AB. Chemodenervation therapy: Techniques and indications. In: Clinical Strabismus Management. Rosenbaum, Santiago (eds.), W.B. Saunders Co.: Philadelphia 1999; Chapter 32: 423-32. | | Scott AB (1998). Botulinum toxin treatment of strabismus. In: Strabismus. Consejo Latinoamericano de Estrabismo (CLADE ; 77-83. | |
Scott AB (1997).
Preventing ptosis after botulinum treatment [In blepharospasm].
Ophthalmic, Plastic and Reconstructive Surgery; 13(2), 81-83.
| | Scott AB (1996). Adaptations of the oculomotor system. In: Proceedings of CLADE (Consejo Latino-Americano de Estrabismo), XII Congress, Buenos Aires, Prieto-Diaz J (ed.), May ; 509-11. | | Scott AB (1996). Botulinum toxin treatment of ocular alignment disorders. In: Proceedings of the International Conference on Biomedical Aspects of Clostridial Neurotoxins. Oxford, July 7-11. | | Scott AB (1994). Posterior fixation: adjustable and without posterior sutures. In: Update on Strabismus and Pediatric Ophthalmology: Transactions of the Joint Congress, June 19-23. | | Tyler CW, Scott AB (1979). Binocular Vision. In: Duane's Foundations of Clinical Ophthalmology. Tasman, Jaeger (eds.), J.B. Lippincott Co.: Philadelphia 1994; Chapter 24: 643-71. | | Scott AB (1994). Change of eye muscle sarcomeres according to eye position. J Pediatr Ophthalmol Strabismus. Mar-Apr; 31(2): 85-8. | | Scott AB (1993). Botulinum and Tetanus Neurotoxins: Neurotransmission and Biomedical Aspects. Das Gupta BR (ed.), Plenum Press, New York; 557-8. | | Scott AB, Miller JM, Collins CC (1992). Eye muscle prosthesis. J Ped Ophthalmol Strabis; 29: 216-8. | | Scott AB, Magoon EH, McNeer K, Stager DR (1990). Botulinum treatment of childhood strabismus. In: Strabismus and Ocular Motility Disorders. Campos EC (ed.), The Macmillan Press Ltd; 403-7. | | Scott AB (1990). Botulinum toxin treatment of strabismus. In: Strabismus and Ocular Motility Disorders. Campos EC (ed.), The Macmillan Press Ltd.; 401-2. | | Scott AB (1990). Botulinum treatment of strabismus following retinal detachment surgery. Arch Ophthalmol.; 108: 509-10. | | Scott AB (1989). Botulinum toxin / role in ophthalmology. Focal Points: Clinical Modules for Ophthalmologists; 7: module 12. | | Scott AB (1988). Antitoxin reduces botulinum side effects [In blepharospasm]. Eye; 2(1): 29-32. | | Magoon E, Scott AB (1987). Botulinum toxin chemodenervation in infants and children: an alternative to incisional strabismus surgery. J. Pediatr; 110: 719-22. | | Scott AB (1986). Botulinum treatment for blepharospasm. In: Ophthalmic Plastic and Reconstructive Surgery. Smith BC (ed.), St. Louis: Mosby Co.; 609-613. | | Scott AB, Kennedy RA, Stubbs HA (1985). Botulinum toxin injection as a treatment for blepharospasm. Arch Ophthalmol.; 103: 347-50. | | Scott AB, Kraft SP (1985). Botulinum toxin injection in the management of lateral rectus paresis. Ophthalmology; 92(5): 676-683. | | Scott AB (1984). Injection treatment of endocrine orbital myopathy. Docum Ophthalmol; 58: 141-145. | | Scott AB (1981). Botulinum Toxin Injection of Eye Muscles to Correct Strabismus. Transactions of the Am. Ophthalmol. Society; 79: 734-70. | | Scott AB (1980). Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery. Ophthalmology; 87: 1044-9. | | Scott AB (1979). Ocular Motility. In: Physiology of the Human Eye and Visual System. Records R (ed.), Hagerstown: Harper & Row; 577-642. | | Scott AB (1978). Upshoots & downshoots. In: Smith-Kettlewell Symposium on Basic Sciences in Strabismus. Annex to V Congress of CLADE. Souza-Dias C (ed.), Sao Paolo: Edicoes Loyola; 60-5. | | Scott, AB (1975). Disinserted extraocular muscles. (Identification by muscle stimulation) Am J Ophthalmol. Feb;79(2):289-91. | |
